The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of next-generation sequencing for prostate cancer in the context of a changing treatment landscape.
 
Jacqueline R. Griffin
Employment - Sema4
 
Tomi Jun
Employment - Sema4
 
Bobby Chi-Hung Liaw
Consulting or Advisory Role - Amgen; Baxter; Daiichi Sankyo; Eisai; EMD Serono; Exelixis; Genomic Health; Myovant Sciences
Research Funding - Bayer; Sanofi
 
Sunny Guin
Employment - Sema4
Stock and Other Ownership Interests - Sema4
 
Che-Kai Tsao
Consulting or Advisory Role - Clovis Oncology; Eisai; Merck
Research Funding - Exelixis; Exelixis
 
Vaibhav G. Patel
No Relationships to Disclose
 
Michael Rossi
Employment - Sema4
Stock and Other Ownership Interests - Sema4
 
Xiang Zhou
Employment - Sema4
Leadership - Sema4
Stock and Other Ownership Interests - Sema4
 
Feras Hantash
Employment - Sema4
Stock and Other Ownership Interests - Sema4
Patents, Royalties, Other Intellectual Property - Quest Diagnostics
 
Rong Chen
Employment - Sema4
Stock and Other Ownership Interests - Sema4
Patents, Royalties, Other Intellectual Property - ZDOCK, RDOCK
 
William K. Oh
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bayer; Conjupro Biotherapeutics; Foundry; HUYA Bioscience International; Janssen; Sanofi; Sema4; TeneoBio